CHRONOLOGY OF THE DEVELOPMENT OF BK-POLYOMAVIRUSES INFECTION IN PATIENTS AFTER KIDNEY TRANSPLANTATION

Lisova G. V., Zheleznikova M. O., Andonieva N. M.

CLINICAL AND EXPERIMENTAL MEDICINE

Scentific article

Kidney allotransplantation currently is a routine method of radical treatment of end-stage renal disease. In the early post-transplant period, the main causes of kidney transplant dysfunction are acute rejection crises and infectious complications. Intensive immunosuppressive therapy is considered to be one of the main risk factors for infectious complications. Viruses cause at least 50% of all infections in kidney transplant recipients. BKpolyomavirus-associated graft dysfunction is a serious disease in patients after kidney translantation, the incidence of which varies from 1% to 10%, with the percentage of loss of graft function reaches 80%. The aim of the work was to study the chronology of the development of BK infection during the first year after kidney transplantation and to monitoring the functional state of the kidneys in recipients with polyomavirus infection. The object and methods of research. There are 50 patients with transplanted kidneys during the first year after transplantation were examined. Results and consideration. The frequency of detection of BK viruria and/or viremia was 24%. The frequency of viruria for BK-polyomavirus was 10 cases (20%), the frequency of BK viremia was 8 cases (16%), simultaneous detection of the virus in blood and urine was observed in 6 cases (12%). During the first year after transplantation, the first cases of laboratory detection of polyomavirus were reported 3 weeks after surgery, with a gradual increase in the level of registration in recipients to 24% for 2 months, followed by a decrease to 8% for the 5th month and episodic detection of the virus by the end of the 1st year. Analysis of the values of indicators of renal functional status in patients of group II revealed a significant decrease of GFR, as well as higher figures of creatinine and urea of blood and albuminuria compared with patients of group I (p< 0.05). When the virus disappeared from the blood and urine, the functional state of the kidneys improved. There was no significant difference between the type of calcineurin inhibitor (cyclosporine or tacrolimus) that the recipient took and the functional state of the kidneys (p=0.001). There was no significant difference between the indicators of clinical blood analysis in patients of group II compared with patients of group I. Conclusions. Activation of BK polyomavirus infection is a common problem that is underestimated in patients after kidney transplantation. It is associated with a decrease of function of the kidney transplant and requires mandatory monitoring. During the first year after surgery, there is a tendency to activate the BK virus from 3 weeks to 5 months after transplantation, which leads to a deterioration in the functional state of the kidney transplant.

chronic kidney disease, kidney transplantation, poliomavirus infection, viremia, viruria.

1.  Anzivino E, Bellizzi A, Mitterhofer AP, Tinti F, Barile M, Colosimo MT, et al. Early monitoring of the human polyomavirus BK replication and sequencing analysis in a cohort of adult kidney transplant patients treated with basiliximab. Virol J. 2011;8:407.
2. Comoli P, Cioni M, Basso S, Gagliardone C, Potenza L, Verrina E, et al. Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity. Clin Dev Immunol. 2013:25-27.
3.  Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis. 2009;199:837-46.
4. Beimler J, Sommerer C, Zeier M. The influence of immunosuppression on the development of BK virus nephropathy – does it matter? Nephrol Dial Transplant. 2007;22(8):66-71.
5. Bohl DL, Brennan DC. BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol. 2007;2(1):36-46.
6. Garces JC. BK Virus-Associated Nephropathy in Kidney Transplant Recipients. Ochsner J. 2010;10:245-9.
7. Ranjan R, Rani A, Brennan DC, Finn PW, Perkins DL. Complete Genome Sequence of BK Polyomavirus Subtype Ib-1 Detected in a Kidney Transplant Patient with BK Viremia Using Shotgun Sequencing. Genome Announc. 2017;5:pii e01474-16.
8. Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DW, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol. 2003 Sep;71(1):115-23.
9.  Sawinski D, Goral S. BK virus infection: an update on diagnosis and treatment. Nephrol Dial Transplant. 2015;30:209-17.
10. Hirsch HH, Vincenti F, Friman S, Tuncer M, Citterio F, Wiecek A, et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant. 2013;13:136-45.
11.  Shah KV. Human polyomavirus BKV and renal disease. Nephrol Dial Transplant. 2000;15:754-5.
12.  Randhawa P, Brennan DC. BK virus infection in transplant recipients: an overview and update. American Journal of Transplantation. 2006;6(9):2000-5.

«Bulletin of problems biology and medicine» Issue 1 Part 2 (149), 2019 year, 163-166 pages, index UDK 616.1:616.831-055:612.13:611.1:577.169:616.127:616.45-001.1/3-08

10.29254/2077-4214-2019-1-2-149-163-166